insights_auto
Why is ALLO up 2.11%?
Dive Deeperchevron_right
ALLO:NASDAQ
Allogene Therapeutics Inc
$1.26
arrow_upward
+2.11%(+0.026) 1D
Oct 28, 1:55:26 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALLO...
Open
$1.22
High
$1.34
Low
$1.21
Mkt. cap
433.94M
Avg. vol.
6.53M
Volume
6.08M
52-wk high
$4.46
52-wk low
$1.04
EPS
-$0.67
Beta
0.56
Shares outstanding
345.49M
No. of employees
150
Open
$1.22
High
$1.34
Low
$1.21
Mkt. cap
433.94M
Avg. vol.
6.53M
Volume
6.08M
52-wk high
$4.46
52-wk low
$1.04
EPS
-$0.67
Beta
0.56
Shares outstanding
345.49M
No. of employees
150
News stories
From web sources and news partners
BigGo Finance
·
1 hour ago
Wall Street Warns of an 8% S&P 500 Slide Before Year-End Rally
ChartMill
·
25 minutes ago
S&P 500 Top Movers: October 28 Gainers and Losers
Yahoo Finance
·
1 hour ago
Prediction: This Dividend Growth ETF Will Outperform the Vanguard S&P 500 ETF Over the Next 20 Years. Here's Why.
Reuters Connect
·
1 day ago
Licensable picture: TUNISIA-ILLUSTRATION-S&P500-STOCK-MARKET
About Allogene Therapeutics Inc
CEO-
Employees150
Founded2017
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websiteallogene.com